Abstract:As an important biomarker for early Alzheimer’s disease (AD) diagnostics and a valuable therapeutic target, amyloid β peptide (Aβ) in blood has attracted extensive attention concerning its detection and monitoring. The tough challenges for monitoring subtle changes of Aβ in blood are low expression and high interference from environmental factors. Here, we constructed a ratiometric sensor based on dual-emission luminescent lanthanide metal–organic coordination polymer (DE-LMOCP) as fluorescence probe for simple, sensitive and accurate detection of Aβ. The DE-LMOCP (luminol-Tb-GMP-Cu) fluorescent probe was composed of terbium ion(Tb3+) as the center metal ions, cupric ion(Cu2+) as a cofactor for Tb3+ fluorescence silence, guanine monophosphate (GMP) as a bridging ligand can strengthen the fluorescence of Tb3+, and luminol as an auxiliary ligand. In the DE-LMOCP fluorescent probe, the fluorescence of the GMP-Tb is quite weak because the existing cofactor Cu2+ prevents the energy transfer of intramolecular between GMP and Tb3+ and results in the quench of GMP-Tb fluorescence. The fluorescence of luminol acts as inner reference. In the presence of Aβ, the high binding affinity of Aβ for Cu2+ causes a remarkable emission enhancement of GMP-Tb and suppresses the quenching effect. However, the fluorescence emission of luminol remains constant as inner reference. Hence, sensitive and accurate determination of Aβ were performed by the ratio of the fluorescence of luminol (F430) to the Tb3+(F547). With this ratiometric probe, Aβ was determined with sensitivity down to 20 pM. Moreover, the ratiometric probe was successfully used to the detection of Aβ in human plasma with satisfactory results due to its capability to eliminate auto-fluorescence. Significantly, it exhibited sound specificity and selectivity to recognize Aβ1−40, and successfully applied to visual detection of Aβ, which validates the potential on-site application. Given the analytical characteristics with high sensitivity, specificity, and accuracy, the ratiometric fluorescence sensor may have great potential in applications of Aβ1−40 detection and the early diagnosis of Alzheimer’s disease, as well as point-of-care tests.

Development of SERS Active Nanoprobe for Selective Adsorption and Detection of Alzheimer's Disease Biomarkers Based on Molecular Docking

Label‐Free Surface‐Enhanced Raman Spectroscopy Detection of Amyloid Beta on Silver Nanostructured Substrates for Alzheimer's Diagnosis

Robust and Universal SERS Sensing Platform for Multiplexed Detection of Alzheimer's Disease Core Biomarkers Using PAapt-AuNPs Conjugates.

Ultrasensitive Detection of Blood-Based Alzheimer's Disease Biomarkers: A Comprehensive SERS-Immunoassay Platform Enhanced by Machine Learning

Hybridization chain reaction triggered poly adenine to absorb silver nanoparticles for label-free electrochemical detection of Alzheimer's disease biomarkers amyloid β-peptide oligomers

Label-Free SERS Strategy for in Situ Monitoring and Real-Time Imaging of Aβ Aggregation Process in Live Neurons and Brain Tissues.

Regenerable and Simultaneous Surface Plasmon Resonance Detection of Aβ(1−40) and Aβ(1−42) Peptides in Cerebrospinal Fluids with Signal Amplification by Streptavidin Conjugated to an N-Terminus-Specific Antibody

Alzheimer’s Disease Determination by a Dual Probe on Gold Nanourchins and Nanohorn Hybrids

Construction of a microcavity-based microfluidic chip with simultaneous SERS quantification of dual biomarkers for early diagnosis of Alzheimer's disease

Chiral Plasmonic Triangular Nanorings with SERS Activity for Ultrasensitive Detection of Amyloid Proteins in Alzheimer's Disease

Detection of a Biomarker for Alzheimer's Disease from Synthetic and Clinical Samples Using a Nanoscale Optical Biosensor

In-situ nanozyme catalytic amplification coupled with a universal antibody orientation strategy based electrochemical immunosensor for AD-related biomarker

Ultrasensitive electrochemical detection of amyloid-beta oligomers using double amplification strategy by MXene substrate and covalent organic framework-based probe

Smart Near-Infrared Fluorescence Probes with Donor–Acceptor Structure for in Vivo Detection of Β-Amyloid Deposits

Label-Free Analysis of Protein Biomarkers Using Pattern-Optimized Graphene-Nanopyramid SERS for the Rapid Diagnosis of Alzheimer’s Disease

Surface-functionalized SERS platform for deep learning-assisted diagnosis of Alzheimer's disease

Self-calibrating surface-enhanced Raman scattering-lateral flow immunoassay for determination of amyloid-β biomarker of Alzheimer's disease

In Situ Monitoring the Aggregation Dynamics of Amyloid-β Protein Aβ42 in Physiological Media Via a Raman-Based Frequency Shift Method.

Rhodanine composite fluorescence probes to detect amyloid-beta aggregated species in Alzheimer's disease models

Exploring Interactions of Aptamers with Aβ40 Amyloid Aggregates and Its Application: Detection of Amyloid Aggregates.

Efficient ratiometric fluorescence probe based on dual-emission luminescent lanthanide coordination polymer for amyloid β-peptide detection